Z-VAD-FMK C22H30FN307

Z-VAD-FMK C22H30FN307

To Order Now: info@anbioq.org

Z-VAD-FMK

abx076838-1mg 1 mg
EUR 342

Z-VAD-FMK

HY-16658B 10mg
EUR 655

Z-VAD-FMK

A1902-1 1 mg
EUR 113
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-10 10 mg
EUR 340
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-25 25 mg
EUR 514
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-5 5 mg
EUR 224
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD-FMK

A1902-5.1 10 mM (in 1mL DMSO)
EUR 224
Description: Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2.

Z-VAD(OMe)-FMK

HY-16658 10mg
EUR 394

Z-VAD-FMK, cell permeable

GL1523-1MG 1 mg
EUR 275

Z-VAD-FMK, cell permeable

GL1523-5MG 5 mg
EUR 792

Caspase-Family Inhibitor Z-VAD-FMK

1010-100
EUR 196

Caspase-Family Inhibitor Z-VAD-FMK

1010-20C
EUR 196

SRB-VAD-FMK [Sulforhodamine B-VAD-FMK]

13472 25 Tests
EUR 132

FITC-VAD-FMK

9497-100
EUR 359

Biotin-VAD-FMK

1123-20C
EUR 327

FAM-VAD-FMK

13470 25 Tests
EUR 132

TF4-VAD-FMK

13471 25 Tests
EUR 132

Biotin-VAD-FMK

HY-100894 1mg
EUR 1014

Z-VAD-FMK (Pan-specific caspase inhibitor)

SIH-557-1MG 1 mg
EUR 193
Description: The substance Z-VAD-FMK is a pan-specific caspase inhibitor. It is synthetically produced and has a purity of >98%. The pure substance is lyophilized solid or wax which is May be dissolved in DMSO (10 mg/ml).

mFluor™ 450-VAD-FMK

13475 25 Tests
EUR 132

mFluor™ 510-VAD-FMK

13476 25 Tests
EUR 132

Z-YVAD-FMK

1141-1
EUR 338

Z-YVAD-FMK

1141-5
EUR 805

Z-VDVAD-FMK

1142-1
EUR 305

Z-VDVAD-FMK

1142-5
EUR 805

Z-DEVD-FMK

1143-1
EUR 316

Z-DEVD-FMK

1143-5
EUR 805

Z-LEVD-FMK

1144-1
EUR 316

Z-LEVD-FMK

1144-5
EUR 805

Z-VEID-FMK

1146-1
EUR 305

Z-VEID-FMK

1146-5
EUR 805

Z-IETD-FMK

1148-1
EUR 327

Z-IETD-FMK

1148-5
EUR 784

Z-LEHD-FMK

1149-1
EUR 316

Z-LEHD-FMK

1149-5
EUR 767

Z-ATAD-FMK

1152-1
EUR 349

Z-ATAD-FMK

1152-5
EUR 914

Z-FA-FMK

1986-1
EUR 147

Z-FA-FMK

1986-5
EUR 370

Z-AEVD-FMK

B1162-1
EUR 338

Z-VRPR-FMK

B1238-1000
EUR 914

Z-VRPR-FMK

B1238-250
EUR 338

Z-VRPR-FMK

GL3755-1MG 1 mg
EUR 585

Z-VRPR-FMK

GL3755-500UG 500 ug
EUR 355

Z-DEVD-FMK

HY-12466 10mg
EUR 393

Z-IETD-FMK

HY-101297 5mg
EUR 463

Z-FA-FMK

A8170-1 1 mg
EUR 119
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-10 10 mg
EUR 467
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-25 25 mg
EUR 514
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-5 5 mg
EUR 282
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-5.1 10 mM (in 1mL DMSO)
EUR 340
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-FA-FMK

A8170-S Evaluation Sample
EUR 81
Description: Z-FA-FMK is a control peptidic fluoromethylketone (boc-Thr-CH2F), and inhibitor to calpain (Ac-Leu-Leu-norleucinal), cathepsin B (Z-Phe-Ala-CH2F), and CPP32-like proteases (Z-DEVD-CH2F) [1].

Z-DEVD-FMK

A1920-1 1 mg
EUR 113
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-10 10 mg
EUR 340
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-25 25 mg
EUR 514
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-5 5 mg
EUR 224
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-5.1 10 mM (in 1mL DMSO)
EUR 293
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DEVD-FMK

A1920-S Evaluation Sample
EUR 81
Description: Z-DEVD-FMK is a tetrapeptide caspase inhibitor that is considered relatively selective for caspase-31, 2 and has been widely used in in vitro and in vivo models of acute injury to delineate roles for caspase 3 in neuronal cell death.

Z-DQMD-FMK

A1921-1 1 mg
EUR 113
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-10 10 mg
EUR 340
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-25 25 mg
EUR 514
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-5 5 mg
EUR 224
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-5.1 10 mM (in 1mL DMSO)
EUR 432
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-DQMD-FMK

A1921-S Evaluation Sample
EUR 81
Description: Inhibition of caspase-3 processing by Z-DQMD-FMK (Z-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone) did not restore cell number in the zinc-deficient group, but resulted in processing of full-length PKC-? to a 56-kDa fragment1.

Z-VDVAD-FMK

A1922-1 1 mg
EUR 177
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-10 10 mg
EUR 630
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-25 25 mg
EUR 978
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-5 5 mg
EUR 398
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VDVAD-FMK

A1922-S Evaluation Sample
EUR 81
Description: Jurkat T-lymphocytes treated with an irreversible caspase-2 inhibitor, benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethyl ketone (Z-VDVAD-FMK), or stably transfected with pro-caspase-2 antisense (Casp-2/AS) are refractory to cytochrome c release stimulated by etoposide1.

Z-VEID-FMK

A1923-1 1 mg
EUR 177
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-10 10 mg
EUR 630
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-25 25 mg
EUR 978
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-5 5 mg
EUR 398
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-VEID-FMK

A1923-S Evaluation Sample
EUR 81
Description: When compared to other caspase inhibitors, Z-DRHD-FMK inhibited caspase 6 activity more effectively than the general caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethy ketone (Z-VAD-FMK) or the caspase 6 inhibitor Z-Val-Glu(Ome)-Ile-Asp(OMe)-fluoromethyl ketone (Z-VEID-FMK).

Z-WEHD-FMK

A1924-1 1 mg
EUR 113
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK

A1924-10 10 mg
EUR 340
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK

A1924-25 25 mg
EUR 514
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-WEHD-FMK

A1924-5 5 mg
EUR 224
Description: Treatment of infected cells with pan-caspase inhibitor IV and Z-WEHD-FMK, an inhibitor of inflammatory caspases, elicited a near-complete blockage of C. trachomatis-induced cleavage of golgin-84.

Z-YVAD-FMK

A8955-1 1 mg
EUR 235
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK

A8955-5 5 mg
EUR 514
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-YVAD-FMK

A8955-5.1 10 mM (in 1mL DMSO)
EUR 1105
Description: Z-YVAD-FMK is a potent cell-permeable and irreversible inhibitor of caspase-1.In Caco-2 cells, Z-YVAD-FMK significantly decreased the growth inhibition induced by butyrate.

Z-IETD-FMK

B3232-1 1 mg
EUR 328
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK

B3232-5 5 mg
EUR 456
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-IETD-FMK

B3232-5.1 10 mM (in 1mL DMSO)
EUR 1001
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Z-LEHD-FMK

B3233-1 1 mg
EUR 350
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Z-LEHD-FMK

B3233-5 5 mg
EUR 879
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1].Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Calpain Inhibitor, Z-LLY-FMK

B1506-1000
EUR 338

Calpain Inhibitor, Z-LLY-FMK

B1506-250
EUR 218

Caspase-3 inhibitor, Z-DQMD-FMK

2782-1
EUR 142

Caspase-3 inhibitor, Z-DQMD-FMK

2782-5
EUR 414

Caspase-5 Inhibitor Z-WEHD-FMK

1100-100
EUR 196

Caspase-5 Inhibitor Z-WEHD-FMK

1100-20C
EUR 196

Caspase-4 Inhibitor Z-LEVD-FMK

1108-100
EUR 185

Caspase-4 Inhibitor Z-LEVD-FMK

1108-20C
EUR 185

EZSolution? Calpain Inhibitor, Z-LLY-FMK

1125-20C
EUR 185

EMAP-II Inhibitor Z-ASTD-FMK

1127-20C
EUR 262

Caspase-1 Inhibitor Z-YVAD-FMK

1012-100
EUR 196

Caspase-1 Inhibitor Z-YVAD-FMK

1012-20C
EUR 196

Caspase-8 Inhibitor Z-IETD-FMK

1064-100
EUR 196

Caspase-8 Inhibitor Z-IETD-FMK

1064-20C
EUR 196

Caspase-2 Inhibitor Z-VDVAD-FMK

1073-100
EUR 185

Caspase-2 Inhibitor Z-VDVAD-FMK

1073-20C
EUR 185

Caspase-9 Inhibitor Z-LEHD-FMK

1074-100
EUR 207

Caspase-9 Inhibitor Z-LEHD-FMK

1074-20C
EUR 207

Caspase-12 Inhibitor Z-ATAD-FMK

1079-100
EUR 218

Caspase-12 Inhibitor Z-ATAD-FMK

1079-20C
EUR 218

Caspase-3 Inhibitor Z-DEVD-FMK

1009-100
EUR 207

Caspase-3 Inhibitor Z-DEVD-FMK

1009-20C
EUR 207

Caspase-6 Inhibitor Z-VEID-FMK

1011-100
EUR 185

Caspase-6 Inhibitor Z-VEID-FMK

1011-20C
EUR 185

Caspase-8 Inhibitor Z-IETD-FMK

B4096-.02 20 µl (10 mM)
EUR 195
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-8 Inhibitor Z-IETD-FMK

B4096-.1 100 µl (2 mM)
EUR 195
Description: Z-IETD-FMK is an inhibitor of caspase 8 [1].Z-IETD-FMK inhibits T cell proliferation induced by PHA or anti-CD3 plus anti-CD28 without toxicity of resting T cells.

Caspase-9 Inhibitor Z-LEHD-FMK

B4573-.02 20 µl (10 mM)
EUR 195
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Caspase-9 Inhibitor Z-LEHD-FMK

B4573-.1 100 µl (2 mM)
EUR 195
Description: Z-LEHD-FMK is a specific and irreversible inhibitor of caspase-9 [1]. Caspase-9 is an initiator caspase and plays an important role in the mitochondrial death pathway.

Cathepsin B&L Inhibitor Z-Phe-Phe-FMK

1126-20C
EUR 229

FMK

HY-52101A 10mM/1mL
EUR 336

FMK

A3420-10 10 mg
EUR 373
Description: FMK is a potent, highly specific and irreversible ribosomal s6 kinase (RSK) inhibitor with IC50 value of 15 nM.[1]RSK is named for ribosomal protein s6, part of the translational machinery which are serine/threonine kinases and are activated by the MAPK/ERK pathway.

FMK-MEA

HY-52101C 5mg
EUR 681

FMK 9a

HY-100522 10mM/1mL
EUR 467

BOC-Asp(OMe)-FMK [Boc-D(OMe)-FMK]

5311 10 mg
EUR 480

FITC-IETD-FMK

9533-100
EUR 359

FITC-LEHD-FMK

9534-100
EUR 359

FITC-VDVAD-FMK

9498-100
EUR 359

FITC-DEVD-FMK

9499-100
EUR 359

Biotin-IETD-FMK

1121-20C
EUR 370

FMK Negative Control

1122-100
EUR 175

FMK Negative Control

1122-20C
EUR 175

Biotin-DEVD-FMK

1124-20C
EUR 370

Biotin-VDVAD-FMK

1032-20C
EUR 370

Biotinyl-ASTD-FMK

1985-1000
EUR 603

Biotinyl-ASTD-FMK

1985-500
EUR 349

Boc-D-FMK

1160-1
EUR 218

Boc-D-FMK

1160-5
EUR 533

FAM-LETD-FMK

13416 100 ug
EUR 263

BOC-D-FMK

HY-13229 1mg
EUR 119

Boc-D-FMK

A1904-1 1 mg
EUR 108
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-10 10 mg
EUR 311
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-25 25 mg
EUR 630
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-5 5 mg
EUR 224
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

Boc-D-FMK

A1904-5.1 10 mM (in 1mL DMSO)
EUR 218
Description: Boc-D-FMK is a cell-permeable broad-spectrum caspase inhibitor that fully inhibits the pro-apoptotic effect of tumor necrosis factor-? (TNF?) with the half maximal inhibition concentration IC50 value of 39 ?M [1].

FITC-C6-DEVD-FMK

13406 1 mg
EUR 480

FITC-C6-LEHD-FMK

13407 1 mg
EUR 480

FITC-C6-DEVD-FMK

13408 100 ug
EUR 219

FITC-C6-LEHD-FMK

13409 100 ug
EUR 219

Caspase-10 Inhibitor AEVD-FMK

1112-100
EUR 185

Caspase-10 Inhibitor AEVD-FMK

1112-20C
EUR 185

Caspase-13 Inhibitor LEED-FMK

1115-100
EUR 185

Caspase-13 Inhibitor LEED-FMK

1115-20C
EUR 185

Caspase Inhibitor Boc-D-FMK

1120-20C
EUR 185

Boc-Lys(Z)-Lys(Z)-Lys(Z)-Lys(Z)-OBzl

A-3185.0001 1.0g
EUR 515
Description: Sum Formula: C68H88N8O15; CAS# [62196-20-7]

Boc-Lys(Z)-Lys(Z)-Lys(Z)-Lys(Z)-OBzl

A-3185.0005 5.0g
EUR 1965
Description: Sum Formula: C68H88N8O15; CAS# [62196-20-7]

Z-Eda-eda-z

20-abx180918
  • EUR 272.00
  • EUR 1107.00
  • EUR 481.00
  • 1 g
  • 25 g
  • 5 g

Z-Orn(Z)-OH.DCHA

A6691-100000 100 g
EUR 270
Description: Z-Orn(Z)-OH.DCHA

Z-Orn(Z)-OH.DCHA

A6691-25000 25 g
EUR 160
Description: Z-Orn(Z)-OH.DCHA

Z-Lys(Z)-OH

A6953-100000 100 g
EUR 189
Description: Z-Lys(Z)-OH

Z-Lys(Z)-OH

A6953-25000 25 g
EUR 96
Description: Z-Lys(Z)-OH

Z-Cys(Z)-OH

C-2910.0005 5.0g
EUR 115
Description: Sum Formula: C19H19NO6S; CAS# [57912-35-3]

Z-Cys(Z)-OH

C-2910.0025 25.0g
EUR 321
Description: Sum Formula: C19H19NO6S; CAS# [57912-35-3]

Z-Lys(Z)-OH

C-2925.0025 25.0g
EUR 126
Description: Sum Formula: C22H26N2O6; CAS# [405-39-0]

Z-Lys(Z)-OH

C-2925.0100 100.0g
EUR 334
Description: Sum Formula: C22H26N2O6; CAS# [405-39-0]

Z-Lys(Z)-OSu

C-2930.0005 5.0g
EUR 115
Description: Sum Formula: C26H29N3O8; CAS# [21160-83-8]

Z-Lys(Z)-OSu

C-2930.0025 25.0g
EUR 321
Description: Sum Formula: C26H29N3O8; CAS# [21160-83-8]

Z-Lys(Z)-ONp

C-2935.0005 5.0g
EUR 115
Description: Sum Formula: C28H29N3O8; CAS# [21160-82-7]

Z-Lys(Z)-ONp

C-2935.0025 25.0g
EUR 273
Description: Sum Formula: C28H29N3O8; CAS# [21160-82-7]

Z-Orn(Z)-OH

C-2965.0005 5.0g
EUR 115
Description: Sum Formula: C21H24N2O6; CAS# [2274-58-0]

Z-Orn(Z)-OH

C-2965.0025 25.0g
EUR 225
Description: Sum Formula: C21H24N2O6; CAS# [2274-58-0]

Z-Orn(Z)-OH

C-2965.0100 100.0g
EUR 611
Description: Sum Formula: C21H24N2O6; CAS# [2274-58-0]

Z-Dab(Z)-OH

C-3690.0001 1.0g
EUR 200
Description: Sum Formula: C20H22N2O6; CAS# [55478-23-4]

Z-Dab(Z)-OH

C-3690.0005 5.0g
EUR 696
Description: Sum Formula: C20H22N2O6; CAS# [55478-23-4]

Z-Dap(Z)-OH

C-3695.0001 1.0g
EUR 200
Description: Sum Formula: C19H20N2O6; CAS# [65621-26-3]

Z-Dap(Z)-OH

C-3695.0005 5.0g
EUR 696
Description: Sum Formula: C19H20N2O6; CAS# [65621-26-3]

Z-Arg(Z)2-OH

20-abx181377
  • EUR 203.00
  • EUR 620.00
  • EUR 286.00
  • 1 g
  • 25 g
  • 5 g

Z-Lys(Z)-Ser-OH

C-2955.0001 1.0g
EUR 151
Description: Sum Formula: C25H31N3O8; CAS# [106326-29-8]

Z-Arg(Z)2-OH

C-2975.0005 5.0g
EUR 139
Description: Sum Formula: C30H32N4O8; CAS# [14611-34-8]

Z-Arg(Z)2-OH

C-2975.0025 25.0g
EUR 441
Description: Sum Formula: C30H32N4O8; CAS# [14611-34-8]

Z-Arg(Z)2-OH

C-2975.0100 100.0g
EUR 1264
Description: Sum Formula: C30H32N4O8; CAS# [14611-34-8]

Z-Arg(Z)2-OSu

C-2985.0005 5.0g
EUR 273
Description: Sum Formula: C34H35N5O10; CAS# [132160-73-7]

Z-Arg(Z)2-OSu

C-2985.0025 25.0g
EUR 998
Description: Sum Formula: C34H35N5O10; CAS# [132160-73-7]

Z-D-Lys(Z)-OH

C-3035.0001 1.0g
EUR 115
Description: Sum Formula: C22H26N2O6; CAS# [69677-02-7]

Z-D-Lys(Z)-OH

C-3035.0005 5.0g
EUR 309
Description: Sum Formula: C22H26N2O6; CAS# [69677-02-7]

Z-D-Lys(Z)-OH

C-3035.0025 25.0g
EUR 1143
Description: Sum Formula: C22H26N2O6; CAS# [69677-02-7]

Z-DL-Lys(Z)-OH

C-3040.0005 5.0g
EUR 115
Description: Sum Formula: C22H26N2O6; CAS# [55592-85-3]

Z-DL-Lys(Z)-OH

C-3040.0025 25.0g
EUR 273
Description: Sum Formula: C22H26N2O6; CAS# [55592-85-3]

Z-D-Orn(Z)-OH

C-3610.0001 1.0g
EUR 115
Description: Sum Formula: C21H24N2O6; CAS# [13594-49-5]

Z-VAD-FMK C22H30FN307